onsiderable experimental evidence suggests that lipid peroxides on LDL and their breakdown products are responsible for the physical changes in the LDL particle and the fragmentation of its apolipoprotein B, which permit it to bind to a wide range of high-affinity receptors on cells in the arterial wall, such as endothelial cells, macrophages, and smooth muscle cells, which are key players in atherosclerosis. 1 Fat-soluble antioxidant vitamins in vitro delay the oxidation of LDL, 2 suggesting that they might have the therapeutic potential to protect against coronary heart disease (CHD). 3] They act as antioxidants only when they are more susceptible to oxidation than the molecules they protect, and once oxidized, they can become pro-oxidants. Additionally, erosion of their potential benefit may stem from their effect in increasing cholesteryl ester heteroexchange 6,7 which is increasingly being viewed as proatherogenic. 8 -10 It could explain the amelioration by high-dose antioxidant vitamins of the regression of coronary atheroma induced by lipid-lowering drugs. 11
No takes yet. Share an insight, caveat, or question.
Durrington et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: